ftInvstr
DCAL · Healthcare ₹167.0 +2.97% Mkt Cap ₹2612 Cr

DCAL

Healthcare Biotechnology
₹167.0
+2.97% today · 30d +12.53%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for DCAL. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹851 Cr
+18.85% YoY
NET PROFIT
₹22 Cr
-49.55% YoY
OPM
20.67%
-1.51pp YoY
EPS
₹1.39
PE 169.9
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-37.1%, h2=-38.5%, h3=-38.4% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
DCAL169.93.0
BIOCON175.486.88
ANTHEM87.931.1
ONESOURCE—4.57
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
44
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation STRETCHED 5
Growth STRONG 70
Profitability DECENT 52
Technicals NEUTRAL 50
Risk LOW 80
Key Stats
TTM PE
169.9
P/B
0.41
52W HIGH
₹303.0
OFF HIGH
-44.88%
DIV YIELD
0.0%
MKT CAP
₹2612 Cr
◉ Active Signals
MACDBullish3.0598
RSI(14)Bullish65.39
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold DCAL and at what entry.

Sign up freeSign in